Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

31.42
Delayed Data
As of Jul 29
 -0.05 / -0.16%
Today’s Change
27.62
Today|||52-Week Range
49.59
-26.52%
Year-to-Date
Sam Isaly Swaps 3 Health Care Stocks in Second Quarter
Jul 29 / GuruFocus News - Paid Partner Content
Whta's in Store for Endocyte (ECYT) this Earnings Season?
Jul 28 / Zacks.com - Paid Partner Content
Keryx (KERX) Q2 Earnings Preview: Will the Stock Gain?
Jul 29 / Zacks.com - Paid Partner Content
4 Low P/CF Stocks to Improve Your Value Investing
Jul 22 / Zacks.com - Paid Partner Content
What's in Store for Prothena (PRTA) This Earnings Season?
Jul 29 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close31.47
Today’s open31.39
Day’s range30.63 - 31.51
Volume493,152
Average volume (3 months)619,264
Market cap$2.3B
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-33.33%
Earnings growth (this year)+22.05%
Earnings growth (next 5 years)+16.30%
Revenue growth (last year)+44.36%
P/E ratio65.2
Price/Sales3.58
Price/Book2.15

Competitors

 Today’s
change
Today’s
% change
RAREUltragenyx Pharmaceu...+2.27+3.72%
GLPGGalapagos NV-0.12-0.22%
IRWDIronwood Pharmaceuti...-0.21-1.46%
GWPHGW Pharmaceuticals P...0.000.00%
Data as of 3:59pm ET, 07/29/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)$0.33
Annual revenue (last year)$860.5M
Annual profit (last year)$39.0M
Net profit margin4.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts

Partner Offers

Search for Jobs